#Opdivo
LightNews LightNews
timprice.bsky.social
They ran out of drug names. These are just random letters
OPDIVO Quantig
October 3, 2025 at 2:12 AM
timprice.bsky.social
“Ask your doctor about Opdivo Qvantig” Okay but I’m worried she’ll think I’m having a stroke
October 3, 2025 at 2:13 AM
frovo.bsky.social
[pharmaceutical hq]

CEO: we need some new drug names

MKTG GUY: cymbalta fabhalta veozah

VP: ar-are you ok

MKTG GUY: kisqali austedo phexxi

VP: sir he’s having a stroke

MKTG GUY: xgeva toujeo zeposia

VP: we should call 911

MKTG GUY: xeljanz opdivo wegovy

CEO: *writing* now let’s not be hasty
June 6, 2025 at 3:26 PM
itsarghh.bsky.social
Lowkirkuinely empirically characterizing the dissociation of opdivo from its target antigen…
September 24, 2026 at 12:30 AM
drjanicekirsch.bsky.social
BIG PHARMA GIVEAWAY

Important cancer drugs will be exempted from negotiation:
1- Keytruda (pembrolizumab) for lung cancer,
2- Opdivo (nivolumab) for lung,kidney cancer, lymphoma, and melanoma,
3- Darzalex (daratumumab) for myeloma

WE will pay higher drug costs.
October 22, 2025 at 1:26 AM
factpoint.bsky.social
The NHS in England has introduced a groundbreaking five-minute injection of the cancer drug nivolumab (Opdivo), replacing traditional IV infusions. Approved by the MHRA, this treatment targets 15 types of cancer, including lung, kidney, and skin cancers.
May 18, 2025 at 7:51 AM
spamps.bsky.social
OPDIVO QVANTIG!!!! OPDIVO QVANTIG!!!! OPDIVO QVANTIG!!!! OPDIVO QVANTIG!!!! OPDIVO QVANTIG!!!! OPDIVO QVANTIG!!!! OPDIVO QVANTIG!!!! OPDIVO QVANTIG!!!! OPDIVO QVANTIG!!!! OPDIVO QVANTIG!!!! OPDIVO QVANTIG!!!! OPDIVO QVANTIG!!!! OPDIVO QVANTIG!!!! OPDIVO QVANTIG!!!! OPDIVO QVANTIG!!!! OPDIVO QVANTIG!
March 16, 2026 at 3:11 AM
reuters.com
Bristol Myers sues Amgen over proposed Opdivo biosimilar reut.rs/4xrSxww
Bristol Myers sues Amgen over proposed Opdivo biosimilar
Bristol Myers Squibb and Ono Pharmaceutical have sued Amgen in Delaware federal court, seeking to block Amgen's proposed U.S. ​biosimilar of their blockbuster cancer immunotherapy drug Opdivo.
reut.rs
September 15, 2026 at 6:15 PM
ohnohedidnt24.bsky.social
Next up: Taelon Peter drafted during an Opdivo Qvantig commercial
June 27, 2025 at 2:09 AM
oncodaily.bsky.social
Bristol Myers Squibb’s Opdivo-Plus-Chemotherapy Regimen for Classical Hodgkin Lymphoma Receives FDA Priority Review

@fda.gov

oncodaily.com/voices/brist...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #BristolMyersSquibb #BMS #HodgkinLymphoma #cHL
Bristol Myers Squibb’s Opdivo-Plus-Chemotherapy Regimen for Classical Hodgkin Lymphoma Receives FDA Priority Review - OncoDaily
Bristol Myers Squibb’s Opdivo-Plus-Chemotherapy Regimen for Classical Hodgkin Lymphoma Receives FDA Priority Review / Bristol Myers Squibb, cancer, FDA,
oncodaily.com
December 13, 2025 at 1:03 AM
rasushrestha.bsky.social
💊 Drug companies stand to lose more than $400 billion in revenue as patents expire for Keytruda, Eliquis, Jardiance, Opdivo, and other blockbuster therapies. ~ @statnews.com

THIS will be a huge catalyst for deals at #JPM2025 this year!

#JPM25 #biopharma #medsky
Drug companies stand to lose more than $400 billion in revenue as patents expire for Keytruda, Eliquis, Jardiance, Opdivo, and other blockbuster therapies.
January 12, 2025 at 2:45 PM
cerebrodigital.net
En un avance revolucionario para el tratamiento del cáncer, Inglaterra se ha convertido en el primer país de Europa en ofrecer a los pacientes una versión inyectable del fármaco de inmunoterapia nivolumab, conocido comercialmente como Opdivo.👇
May 6, 2025 at 7:47 PM
scientistswanda.bsky.social
Immunotherapy is changing the way we fight cancer, and Opdivo is at the forefront. Instead of attacking cancer directly, it empowers your immune system to recognize and destroy cancer cells. Curious about the science behind this breakthrough? Check out my quick explainer video.
youtu.be/VzUAZNQ_NpY
How does Opdivo (Nivolumab) Work?
YouTube video by Dr. Rob Swanda
youtu.be
January 6, 2026 at 10:17 PM
genericuser1234567.bsky.social
I'm excited for when Opdivo and Keytruda finally have their parents expire. That stuff retails for $30k/gram and $60k/gram.

The manufacturing cost? $100-200/gram
April 5, 2026 at 3:37 AM
tomatosoup74.bsky.social

FDA approval! I've worked on this trial for 4 years.
You may have seen commercials for the cancer treatment Opdivo, and this new formulation is given subcutaneously (a shot under the skin) in 5 min 1x/month vs. a 30+ minute IV infusion.
(1/2)
#CancerResearch

news.bms.com/news/details...
U.S. Food and Drug Administration Approves Opdivo Qvantig™ (nivolumab and hyaluronidase-nvhy) Injection, for Subcutaneous Use in Most Previously Approved Adult, Solid Tumor Opdivo® (nivolumab) Indicat...
Opdivo Qvantig is the first and only subcutaneously administered PD-1 inhibitor1 Given over three- to five-minutes, Opdivo Qvantig demonstrated consistent efficacy and showed a comparable safety profi...
news.bms.com
January 15, 2025 at 4:03 PM
viveksubbiah.bsky.social
🚨It’s Friday & we have another FDA approval 👉🏼FDA Approves Subcutaneous Nivolumab in Advanced or Metastatic Solid Tumors onclive.com/view/fda-appro… via https://www.onclive.com/view/fda-approves-subcutaneous-nivolumab-in-advanced-or-metastatic-solid-tumors
FDA Approves Subcutaneous Nivolumab in Advanced or Metastatic Solid Tumors
The FDA has approved nivolumab and hyaluronidase-nvhy (Opdivo Qvantig) for subcutaneous injection across approved adult solid tumor nivolumab (Opdivo) indications.
www.onclive.com
December 27, 2024 at 6:50 PM
almiacm.bsky.social
💊 La Comisión Interministerial de Precios de los Medicamentos #CIPM aprueba la combinación Opdivo (nivolumab) y Yervoy (ipilimumab) para cáncer colorrectal metastásico

#MásTiempoParaVivir #CáncerMetastasico #NuevosTratamientos

cancermetastasico.es/cipm-aprueba...
La CIPM aprueba la combinación Opdivo (nivolumab) y Yervoy (ipilimumab) - Asociación de pacientes de cáncer metastásico
La CIPM ha aprobado la financiación de la combinación de Opdivo (nivolumab) y Yervoy (ipilimumab) para CCRm
cancermetastasico.es
October 1, 2026 at 3:43 PM
crzyfkinworld.bsky.social
CBS's top advertisers
*Austedo XR
Movement disorder tablets
*OPDIVO + QVAINTIG Cancer injections
*RINVOQ Rheumatoid arthritis meds
*WeatherTech
floor mats
*Ashley Home
*Good Feet
Arch‑support
*NoTimeToWait.com
*NERVIVE
Nerve pain relief
*TEPEZZA
Thyroid‑eye disease treatment
*ULTOMIRIS (Alexion)
crzyfkinworld.bsky.social FEISTY😈 @crzyfkinworld.bsky.social · Jul 23
The Late Show with Stephen Colbert being canceled wasn't enough for Trump.

Paramount has agreed to give him 20 million dollars of free advertising.

That is in addition to the 16 million they agreed to pay him over the 60 Minutes BS.

Here is a list of channels that Paramount owns.
Key Channels CBS Entertainment CBS, CBS Sports Network, Dabl, Favo TV, The CW MTV Entertainment MTV, Comedy Central, VH1, CMT, Paramount Network, Pop, Smithsonian Channel…. Nickelodeon Group Nickelodeon, Nick Jr., Nickloons, TeenNick, NickMusic Showtime Networks Showtime & its spin-off channels + The Movie Channel, Flix BET Media Group BET, BET Gospel/Her/Jams/Soul CBS News & Stations Local CBS affiliates, streaming/24-hr news, CBS News Radio
July 23, 2025 at 4:54 PM
linareed72.bsky.social
Thank you all for your positive thoughts it has worked. The OPDIVO treatments are doing their job!! Great PT Scan for the cancer cells are all but gone. Of course, the rest of the body is in need of a repair but that will wait until the treatments are over. I am so very grateful for good news. 💓👊👍
July 12, 2025 at 1:54 PM
hankgreen.bsky.social
I always said “this is the best year so far in human history to get cancer” and John retorted, “yeah, but next year would have been better.”

Truly ridiculous how right he was…
Two years after starting treatment, about 92% of trial participants randomly assigned to the nivolumab–AVD group were alive without their cancer starting to grow again—a measure known as progression-free survival—compared with 83% in the brentuximab–AVD group. People in the nivolumab–AVD group also had fewer side effects overall and fewer serious side effects, according to findings reported October 17 in the New England Journal of Medicine. The immunotherapy drug nivolumab (Opdivo) should be part of the initial treatment of teens and adults with advanced forms of classic Hodgkin lymphoma, according to updated results from a large NCI-funded clinical trial. In the nearly 1,000-patient trial, treatment with nivolumab and a three-drug chemotherapy regimen called AVD was better at eliminating cancer and keeping it at bay than the current standard initial treatment for the disease, AVD combined with the targeted therapy brentuximab (Adcetris).
January 13, 2025 at 4:00 AM
resist61.bsky.social
FDA approves injectable version of Bristol Myers Squibb's cancer drug Opdivo .

Opdivo is part of a class of drugs called PD-1 inhibitors, which enhance the immune system's ability to fight cancer by removing its natural brakes.
Source: Reuters
share.newsbreak.com/alelcuu3
FDA approves injectable version of Bristol Myers Squibb's cancer drug Opdivo - NewsBreak
(Reuters) -The U.S. Food and Drug Administration said on Friday that it has approved an injectable version of Bristol Myers Squibb's blockbuster cancer drug, Opdivo. Opdivo is part of a class of drugs...
share.newsbreak.com
December 28, 2024 at 6:31 AM
ruralfreedomnet.bsky.social
Republicans included language in their Big Ugly Bill to weaken Medicare’s ability to negotiate the price of certain drugs, including cancer treatments Keytruda, Opdivo, and Darzalex. CBO’s report estimates this provision will cost taxpayers $8.8— $10.9 billion over the next decade. -- Richie Neal
October 20, 2025 at 4:30 PM